The new cholesterol medication generating hubbub this week is anacetrapib. Why is the world holding its breath for another cholesterol medicine in an already crowded field?  Well, the most successful family of cholesterol medications is statins.  Statins have solid evidence for stroke and heart attack prevention.  Statins lower LDL, the “bad cholesterol” that you hear about whenever your doctor discusses your cholesterol results.  But another important risk factor for heart disease is low HDL. ...